BioLineRx Ltd. (NASDAQ:BLRX) Q1 2025 Earnings Conference Call May 27, 2025 8:30 AM ET
Company Participants
Irina Koffler – IR, LifeSci Advisors
Philip Serlin – CEO
Mali Zeevi – CFO
Ella Sorani – Chief Development Officer
Conference Call Participants
Joe Pantginis – H.C. Wainwright
Justin Walsh – Jones Trading
John Vandermosten – Zacks
Operator
Ladies and gentlemen, thank you for standing by. Welcome to BioLineRx First Quarter 2025 Financial Results Conference Call. All participants are presently in a listen-only mode. Following managements formal presentation, instructions will be given for the question-and-answer session.
I would now like to turn over the call to Irina Koffler, Investor Relations. Irina, please go ahead.
Irina Koffler
Thank you, operator, and welcome, everyone. Thank you for joining us on our quarterly results conference call. Earlier today, we issued a press release, a copy of which is available in the Investor Relations section of our website. It was also filed as a 6-K.
I’d like to remind you that certain statements we make during the call will be forward-looking. Because such statements deal with future events and are subject to many risks and uncertainties, actual results may differ materially from those in the forward-looking statements. For a full discussion of these risks and uncertainties, please review our annual report on Form 20-F and our quarterly reports on Form 6-K that are filed with the U.S. Securities and Exchange Commission.
At this time, it is now my pleasure to turn the call over to Mr. Phil Serlin, Chief Executive Officer of BioLineRx.
Philip Serlin
Thank you, Irina, and good morning, everyone, and thank you for joining us on today’s call. As has been our practice, I will begin with a few prepared remarks before turning the call over to Mali Zeevi, our Chief Financial Officer, to briefly recap our financials. Afterwards, we will take your questions. Ella Sorani, our
#BioLineRx #BLRX #Earnings #Call #Transcript